The COVID-19 vaccine provided more than a defense against a deadly virus; it introduced mRNA’s transformative journey in modern healthcare.
Stay Updated! Subscribe to The Primer
Share
Breaking Barriers with CRISPR’s Regulatory Approval
CRISPR is a revolutionary gene-editing tool that catalyzes a new era in precision medicine and drives a fierce ethical debate.
Exploring RNA DrugS: Antisense, RNAi, and MicroRNA
RNA-based drug therapy has taken the biotech world by storm, reshaping treatment landscapes with its ability to target “undruggable” areas and provide personalized patient solutions.
Unlocking the Potential of CRISPR
Scientists have repurposed a bacterial immune response against viruses, called CRISPR, to edit the human genome in ways never before possible.
Combatting Obesity: Overcoming the Interplay of Factors
Obesity is far more complex than the chronic consumption of too many calories. Unraveling obesity’s origins and finding effective therapies requires navigating a…
Unlock the Language of Cells with Cell Signaling
In any multicellular organism, individual cells must communicate with each other through complicated cell signaling pathways. Since any…
Groundbreaking Migraine Drug Explained
In May 2018, the FDA approved Amgen’s (Thousand Oaks, CA) new migraine drug Aimovig, the first drug shown to prevent the onset of migraines. The drug significantly reduces the number of migraine days in difficult-to-treat (those that have failed 2 to 4 prior...
The Immune System: Friend & Sometimes Foe
The immune system. Yes, everybody has one. It’s pretty important to our health. But what the heck is it? In short, the immune system is a complicated network of organs, cells, and signaling molecules. Without this guardian, we fall prey to dangerous pathogens and...
Curing the Leading Hereditary Cause of Infant Death
To help bring awareness to Spinal Muscular Atrophy (SMA), the leading hereditary cause of infant death, August has been named National Spinal Muscular Atrophy (SMA) month. In this Primer, we’ll explain SMA and the different therapeutic approaches to tackle this...
Alzheimer’s Disease: The Way Forward
Previously, we reviewed the pathology and genetics of Alzheimer’s disease (AD) and discussed the two most common AD drug development targets, amyloid-beta plaques, and tau. Now, we’ll look at various novel AD drug targets and the companies forging ahead to find new...
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.